PLIVA 459 (Theophylline extended-release 300 mg)
Pill with imprint PLIVA 459 is White, Capsule-shape and has been identified as Theophylline extended-release 300 mg. It is supplied by Pliva Inc.
Theophylline is used in the treatment of apnea of prematurity; asthma, maintenance; asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PLIVA 459
Theophylline extended-release
- Imprint
- PLIVA 459
- Strength
- 300 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Methylxanthines
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pliva Inc.
- National Drug Code (NDC)
- 50111-0459 (Discontinued)
- Inactive Ingredients
-
hypromellose 2208 (100 mPa.s),
lactose anhydrous,
magnesium stearate,
povidone k30
Note: Inactive ingredients may vary.
More about theophylline
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (15)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: methylxanthines
Patient resources
- Drug Information
- Theophylline (Advanced Reading)
- Theophylline Intravenous (Advanced Reading)
- Theophylline Extended-Release Tablets
- Theophylline Extended-Release Capsules
- Other brands
- Theo-24, Theo-Dur, Uniphyl, Elixophyllin, ... +6 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.